![Momenta Pharmaceuticals logo](/news-release/logo/330730/0/330730.jpg?lastModified=12%2F09%2F2016%2022%3A36%3A50&size=2)
Momenta Pharmaceuticals Announces Date of Third Quarter 2014 Financial Results Conference Call and Webcast
October 22, 2014 08:00 ET
|
Momenta Pharmaceuticals
CAMBRIDGE, Mass., Oct. 22, 2014 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, will...
![Momenta Pharmaceuticals logo](/news-release/logo/330730/0/330730.jpg?lastModified=12%2F09%2F2016%2022%3A36%3A50&size=2)
Momenta Pharmaceuticals Announces Top-Line Part A Results From Phase 1/2 Trial of Necuparanib in Patients With Pancreatic Cancer
October 09, 2014 16:15 ET
|
Momenta Pharmaceuticals
CAMBRIDGE, Mass., Oct. 9, 2014 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, announced...
![Momenta Pharmaceuticals logo](/news-release/logo/330730/0/330730.jpg?lastModified=12%2F09%2F2016%2022%3A36%3A50&size=2)
Momenta Pharmaceuticals to Host 2014 R&D Day
October 02, 2014 08:00 ET
|
Momenta Pharmaceuticals
CAMBRIDGE, Mass., Oct. 2, 2014 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today...
![Momenta Pharmaceuticals logo](/news-release/logo/330730/0/330730.jpg?lastModified=12%2F09%2F2016%2022%3A36%3A50&size=2)
Momenta Pharmaceuticals to Webcast Presentation at BioCentury's NewsMakers in the Biotech Industry Conference
September 17, 2014 08:30 ET
|
Momenta Pharmaceuticals
CAMBRIDGE, Mass., Sept. 17, 2014 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today...
![Momenta Pharmaceuticals logo](/news-release/logo/330730/0/330730.jpg?lastModified=12%2F09%2F2016%2022%3A36%3A50&size=2)
Momenta Pharmaceuticals Exercises Option to Acquire Novel Antibodies From AnaptysBio
September 08, 2014 08:30 ET
|
Momenta Pharmaceuticals
CAMBRIDGE, Mass., Sept. 8, 2014 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today...
![Momenta Pharmaceuticals logo](/news-release/logo/330730/0/330730.jpg?lastModified=12%2F09%2F2016%2022%3A36%3A50&size=2)
Momenta Pharmaceuticals Announces Abbreviated New Drug Application for Three-Times-a-Week Generic Copaxone Accepted for Review by FDA
August 28, 2014 09:25 ET
|
Momenta Pharmaceuticals
CAMBRIDGE, Mass., Aug. 28, 2014 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals (Nasdaq:MNTA) today announced that the U.S. Food and Drug Administration (FDA) has accepted for review the Abbreviated New...
![Momenta Pharmaceuticals logo](/news-release/logo/330730/0/330730.jpg?lastModified=12%2F09%2F2016%2022%3A36%3A50&size=2)
Momenta Pharmaceuticals Reports Second Quarter 2014 Financial Results
July 31, 2014 08:00 ET
|
Momenta Pharmaceuticals
CAMBRIDGE, Mass., July 31, 2014 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA) today reported its financial results for the second quarter ended June 30, 2014.
For the second...
![Momenta Pharmaceuticals logo](/news-release/logo/330730/0/330730.jpg?lastModified=12%2F09%2F2016%2022%3A36%3A50&size=2)
Momenta Pharmaceuticals to Webcast Presentation at the Canaccord Genuity Growth Conference
July 30, 2014 16:05 ET
|
Momenta Pharmaceuticals
CAMBRIDGE, Mass., July 30, 2014 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today...
![Momenta Pharmaceuticals logo](/news-release/logo/330730/0/330730.jpg?lastModified=12%2F09%2F2016%2022%3A36%3A50&size=2)
Momenta Pharmaceuticals Announces Date of Second Quarter 2014 Financial Results Conference Call and Webcast
July 15, 2014 16:05 ET
|
Momenta Pharmaceuticals
CAMBRIDGE, Mass., July 15, 2014 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, will...
![Momenta Pharmaceuticals logo](/news-release/logo/330730/0/330730.jpg?lastModified=12%2F09%2F2016%2022%3A36%3A50&size=2)
Momenta Pharmaceuticals to Webcast Presentation at the Wells Fargo Healthcare Conference
June 09, 2014 16:05 ET
|
Momenta Pharmaceuticals
CAMBRIDGE, Mass., June 9, 2014 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today...